Caplin Point Laboratories Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Public

  • Employees
  • 5,455

Employees

  • Stock Symbol
  • 524742

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $21.75
  • (As of Friday Closing)

Caplin Point Laboratories General Information

Description

Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is into the business of pharmaceuticals - producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas markets. The company's key products include: Tablets and capsules, Liquid orals and syrups, Softgel capsules, Injectables (liquid and lyophilized, pre-filled syringes), Ointments, creams, and gels, Powder for injections, Suppositories and ovules, Pre-mix infusion bags, Inhalers and sprays, Oral rehydration salts (ORS), and Sachets.

Contact Information

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Ashvich Towers, Number 3
  • Developed Plots Industrial Estate, Perungudi
  • Chennai, Tamil Nadu 600096
  • India
+91 044
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Corporate Office
  • 3rd Floor, Ashvich Towers, Number 3
  • Developed Plots Industrial Estate, Perungudi
  • Chennai, Tamil Nadu 600096
  • India
+91 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caplin Point Laboratories Stock Performance

As of 20-Nov-2026, Caplin Point Laboratories’s stock price is $21.75. Its current market cap is $1.65B with 76M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$21.75 $22.31 $15.85 - $31.24 $1.65B 76M 14.5K $0.98

Caplin Point Laboratories Financials Summary

As of 30-Sep-2026, Caplin Point Laboratories has a trailing 12-month revenue of $257M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 2,045,501 1,098,236 1,678,386 1,116,613
Revenue 257,027 245,732 227,211 202,879
EBITDA 103,486 91,677 80,385 69,018
Net Income 74,311 72,568 63,426 55,214
Total Assets 455,479 428,762 375,367 323,541
Total Debt 481 489 587 236
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Caplin Point Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Caplin Point Laboratories‘s full profile, request access.

Request a free trial

Caplin Point Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is into the business of pharmaceuticals - pro
Pharmaceuticals
Chennai, India
5,455 As of 2026

Mumbai, India
 

Dhaka, Bangladesh
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Caplin Point Laboratories Competitors (32)

One of Caplin Point Laboratories’s 32 competitors is J. B. Chemicals & Pharmaceuticals, a Formerly PE-Backed company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
J. B. Chemicals & Pharmaceuticals Formerly PE-Backed Mumbai, India
Beximco Pharmaceuticals Corporation Dhaka, Bangladesh
Ciron Drugs And Pharmaceuticals Corporation Mumbai, India
Macleods Pharmaceuticals Corporation Mumbai, India
Emcure Pharmaceuticals Formerly PE-Backed Pune, India
You’re viewing 5 of 32 competitors. Get the full list »

Caplin Point Laboratories Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Caplin Point Laboratories Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Caplin Point Laboratories‘s full profile, request access.

Request a free trial

Caplin Point Laboratories Investments & Acquisitions (3)

Caplin Point Laboratories’s most recent deal was a Merger/Acquisition with Triwin Pharma for . The deal was made on 03-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Triwin Pharma 03-Jun-2025 Merger/Acquisition Pharmaceuticals
Neoethicals Chile 01-Apr-2025 Merger/Acquisition Distributors/Wholesale
Hainan Jointown Caplinpoint Pharmaceutical Company 06-Aug-2018 Joint Venture Pharmaceuticals
To view Caplin Point Laboratories’s complete investments and acquisitions history, request access »

Caplin Point Laboratories ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

27.41 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Caplin Point Laboratories’s complete esg history, request access »

Caplin Point Laboratories FAQs

  • When was Caplin Point Laboratories founded?

    Caplin Point Laboratories was founded in 1990.

  • Where is Caplin Point Laboratories headquartered?

    Caplin Point Laboratories is headquartered in Chennai, India.

  • What is the size of Caplin Point Laboratories?

    Caplin Point Laboratories has 5,455 total employees.

  • What industry is Caplin Point Laboratories in?

    Caplin Point Laboratories’s primary industry is Pharmaceuticals.

  • Is Caplin Point Laboratories a private or public company?

    Caplin Point Laboratories is a Public company.

  • What is Caplin Point Laboratories’s stock symbol?

    The ticker symbol for Caplin Point Laboratories is 524742.

  • What is the current stock price of Caplin Point Laboratories?

    As of 20-Nov-2026 the stock price of Caplin Point Laboratories is $21.75.

  • What is the current market cap of Caplin Point Laboratories?

    The current market capitalization of Caplin Point Laboratories is $1.65B.

  • What is Caplin Point Laboratories’s current revenue?

    The trailing twelve month revenue for Caplin Point Laboratories is $257M.

  • Who are Caplin Point Laboratories’s competitors?

    J. B. Chemicals & Pharmaceuticals, Beximco Pharmaceuticals, Ciron Drugs And Pharmaceuticals, Macleods Pharmaceuticals, and Emcure Pharmaceuticals are some of the 32 competitors of Caplin Point Laboratories.

  • What is Caplin Point Laboratories’s annual earnings per share (EPS)?

    Caplin Point Laboratories’s EPS for 12 months was $0.98.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process